Form 4: Omega Healthcare Investors Director Granted Equity Compensation, Boosting Stake

Lisa Egbuonu-Davis, a Director at Omega Healthcare Investors Inc., was granted 4,388 shares of common stock as compensation, increasing her total beneficial ownership to 21,154 shares.

Summary

• Lisa Egbuonu-Davis, a Director of Omega Healthcare Investors Inc. (OHI), acquired 4,388 shares of common stock on June 6, 2025.
• The acquisition was a Restricted Stock Grant Award Agreement, representing director compensation.
• The granted shares have an implied value of approximately $37.6 per share, based on the reported transaction details.
• Following this transaction, Ms. Egbuonu-Davis's direct beneficial ownership of OHI common stock increased to 21,154 shares.
• The restricted stock grant is scheduled to vest on the date of the Company's 2026 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis.

Sentiment

Score: 6

Explanation: The filing reports a routine director compensation grant, which is a neutral to slightly positive event as it aligns director interests with shareholders. It does not indicate any significant positive or negative operational or financial news for the company.

Positives

• The equity grant aligns the director's financial interests directly with the long-term performance of Omega Healthcare Investors and its shareholders.
• This form of compensation is a standard practice in corporate governance, indicating a routine and expected method of compensating board members.

Risks

• The value of the granted shares is subject to market fluctuations, meaning the actual value realized upon vesting could be higher or lower than the implied grant value of $37.6 per share.

Future Outlook

The 4,388 restricted shares granted to the director are expected to vest on the date of Omega Healthcare Investors' 2026 Annual Meeting of Shareholders, approximately one year from the grant date, and will convert to common stock on a one-for-one basis upon vesting.

Industry Context

Director compensation through equity grants is a prevalent practice across various industries, including the healthcare REIT sector. This method is widely adopted to align the interests of board members with the long-term strategic goals and financial performance of the company, fostering a shared commitment to shareholder value creation.

Comparison to Industry Standards

• The grant of restricted stock as director compensation is a standard and widely accepted practice for publicly traded companies, including those in the healthcare real estate investment trust (REIT) sector.
• This approach is consistent with corporate governance best practices aimed at aligning the interests of non-executive directors with those of shareholders.
• While specific comparable companies or projects are not detailed in the filing, the nature and structure of this equity award are typical for director compensation packages within the industry, designed to attract and retain experienced board members.

Corporate Governance

Related Party Transactions

• The acquisition of 4,388 shares of common stock by Director Lisa Egbuonu-Davis as a Restricted Stock Grant Award Agreement constitutes a related party transaction, as it involves compensation from the company to a member of its board of directors.

Stakeholder Impact

• Shareholders: The equity grant aligns the director's financial incentives with shareholder interests, potentially fostering decisions that enhance long-term share value. However, it also represents a minor dilutive event.
• Management: The Power of Attorney facilitates efficient compliance with SEC reporting requirements for the director, reducing administrative overhead for the company's legal and compliance teams.

Next Steps

• The 4,388 restricted shares granted to Director Lisa Egbuonu-Davis are scheduled to vest on the date of the Company's 2026 Annual Meeting of Shareholders.
• Upon vesting, the restricted shares will convert to common stock on a one-for-one basis.

Key Dates

Keywords

Omega Healthcare Investors, OHI, Form 4, SEC filing, Director compensation, Restricted Stock Grant, Equity award, Insider transaction, Beneficial ownership, Healthcare REIT